A detailed history of Royal Bank Of Canada transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 18,160 shares of PRCT stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,160
Previous 13,434 35.18%
Holding current value
$1.47 Million
Previous $820,000 77.32%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $266,121 - $401,662
4,726 Added 35.18%
18,160 $1.45 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $268,663 - $406,491
5,875 Added 77.72%
13,434 $820,000
Q1 2024

Nov 05, 2024

SELL
$40.38 - $50.75 $237,232 - $298,156
-5,875 Reduced 43.73%
7,559 $373,000
Q1 2024

May 15, 2024

SELL
$40.38 - $50.75 $191,239 - $240,352
-4,736 Reduced 38.52%
7,559 $373,000
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $185,554 - $323,621
7,455 Added 154.03%
12,295 $515,000
Q3 2023

Nov 14, 2023

BUY
$30.02 - $38.81 $38,725 - $50,064
1,290 Added 36.34%
4,840 $158,000
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $34,202 - $47,422
1,281 Added 56.46%
3,550 $125,000
Q1 2023

May 15, 2023

SELL
$26.64 - $39.74 $29,996 - $44,747
-1,126 Reduced 33.17%
2,269 $64,000
Q4 2022

Feb 14, 2023

BUY
$38.78 - $46.78 $100,168 - $120,832
2,583 Added 318.1%
3,395 $141,000
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $5,191 - $8,509
168 Added 26.09%
812 $34,000
Q2 2022

Aug 15, 2022

SELL
$29.23 - $44.45 $8,769 - $13,335
-300 Reduced 31.78%
644 $21,000
Q1 2022

May 16, 2022

SELL
$16.89 - $35.74 $17,937 - $37,955
-1,062 Reduced 52.94%
944 $33,000
Q4 2021

Feb 14, 2022

BUY
$24.6 - $46.29 $37,047 - $69,712
1,506 Added 301.2%
2,006 $50,000
Q3 2021

Nov 15, 2021

BUY
$35.91 - $41.94 $17,955 - $20,970
500 New
500 $19,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.